Mania following vagus nerve stimulation: A case report and review of the literature

Epilepsy and Behavior

Volumn 20, Issue 1, 2011, Pages 138-140

  Gerson, Ruth ^a   Murray, Evan ^b   Price, Bruce ^b   Frankel, Mark ^b   Douglass, Laurie M ^c   Cunningham, Miles ^b  

^a NEW YORK UNIVERSITY   (United States)

^b MCLEAN HOSPITAL   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

Depression; Epilepsy; Mania; Vagus nerve stimulation

Indexed keywords

CITALOPRAM; CLONAZEPAM; DIAZEPAM; ETIRACETAM; LAMOTRIGINE; LORAZEPAM; OXYCODONE; SEROTONIN UPTAKE INHIBITOR; VALPROATE SEMISODIUM; ZONISAMIDE;

ADULT; ANTICONVULSANT THERAPY; ANXIETY; ARTICLE; AUDITORY HALLUCINATION; BENIGN CHILDHOOD EPILEPSY; CASE REPORT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISTRACTIBILITY; DRUG OVERDOSE; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; IRRITABILITY; JUVENILE MYOCLONIC EPILEPSY; LEUKOPENIA; LOGORRHEA; MAJOR DEPRESSION; MANIA; MYOCLONUS; MYOCLONUS EPILEPSY; POSTOPERATIVE PAIN; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT; VAGUS NERVE STIMULATION;

BIPOLAR DISORDER; FEMALE; HUMANS; MYOCLONIC EPILEPSY, JUVENILE; VAGUS NERVE STIMULATION; YOUNG ADULT;

EID: 78651238178     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.11.005     Document Type: Article

References (26)

1. Milby A.H., Halpern C.H., Baltuch G.H. Vagus nerve stimulation for epilepsy and depression. Neurotherapeutics 2008, 5:75-85.
2. George M.S., Belmaker R.H. Transcranial magnetic stimulation in neuropsychiatry 2000, American Psychiatric Press, Washington, DC.
3. Schlaepfer T.E., Frick C., Zobel A., et al. Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychol Med 2008, 38:651-661.
4. Daban C., Martinez-Aran A., Cruz N., Vieta E. Safety and efficacy of vagus nerve stimulation in treatment-resistant depression: a systematic review. J Affect Disord 2008, 110:1-15.
5. George M.S., Rush A.J., Marangell L.B., et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 2005, 58:364-373.
6. Bajbouj M., Merkl A., Schlaepfer T.E., et al. Two year outcome of vagus nerve stimulation in treatment-resistant depression. J Clin Psychopharmacol 2010, 30:273-281.
7. Sperling W., Reulbach U., Kornhuber J. Clinical benefits and cost effectiveness of vagus nerve stimulation in a long-term treatment of patients with major depression. Pharmacopsychiatry 2009, 42:85-88.
8. George M.S., Nahas Z.H., Borckardt J.J., Anderson B., Foust M.J. Nonpharmacological somatic treatments. The American Psychiatric Publishing textbook of psychiatry 2008, American Psychiatric Publishing, Arlington, VA. 5th ed. R.E. Hales, S.C. Yudofsky, G.O. Gabbard (Eds.).
9. Lomarev M., Denslow S., Nahas Z., Chae J.-H., George M.S., Bohning D.E. Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects. J Psychiatr Res 2002, 36:219-227.
10. Zobel A., Joe A., Freymann N., et al. Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: an exploratory approach. Psychiatry Res 2005, 139:165-179.
11. Nahas Z., Teneback C., Chae J.-H., et al. Serial vagus nerve stimulation functional MRI in treatment-resistant depression. Neuropsychopharmacology 2007, 32:1649-1660.
12. Mayberg H.S., Brannan S.K., Tekell J.L., et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 2000, 48:830-843.
13. Brody A.L., Saxena S., Stoessel P., et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry 2001, 58:631-640.
14. Mula M., Monaco F. Antiepileptic drug-induced mania in patients with epilepsy: What do we know?. Epilepsy Behav 2006, 9:265-267.
15. Ghaemi SN, Ko JY, Goodwin FK. "Cade's disease" and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry 2002 Mar;47(2):125-34. Review.
16. Rush A.J., Marangell L.B., Sackeim H.A., et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 2005, 58:347-354.
17. Frick C., Kosel M., Schlaepfer T.E., Stanga Z., Hasdemir M.G. Incident mania during therapy with vagus nerve stimulation. J ECT 2005, 21:197.
18. Nahas Z., Marangell L.B., Husain M.M., et al. Two-year outcome of vagus nerve stimulation for treatment of major depressive episodes. J Clin Psychiatry 2005, 66:1097-1104.
19. Nierenberg A.A., Alpert J.E., Gardner-Schuster E.E., Seay S., Mischoulon D. Vagus nerve stimulation: 2-year outcome for bipolar versus unipolar treatment-resistant depression. Biol Psychiatry 2008, 64:455-460.
20. Marangell L.B., Suppes T., Zboyan H.A., et al. A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder. J Clin Psychiatry 2008, 69:183-189.
21. Sackeim H.A., Rush A.J., George M.S., et al. Vagus nerve stimulation for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001, 25:713-728.
22. Doshi P.K., Chhava N., Bhatt M.H. Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease. Move Disord 2002, 17:1084-1085.
23. Soulas T., Gurruchaga J.M., Palfi S., Cesaro P., Nguyen J.P., Fenelon G. Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson's disease. J Neurol Neurosurg Psychiatry 2008, 79:952-954.
24. Burkhard P.R., Vingerhoets F.J., Berney A., Bogousslavsky J., Villemure J.G., Ghika J. Suicide after successful deep brain stimulation for movement disorders. Neurology 2004, 63:2170-2172.
25. Rush A.J., Siefert S.E. Clinical issues in considering vagus nerve stimulation for treatment-resistant depression. Exp Neurol 2009, 219:36-43.
26. Ashton A.K. Depressive relapse after vagal nerve stimulator explantation [letter to the editor]. Am J Psychiatry 2010, 167:719-720.